Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2008

Web Exclusives

Pomp, Circumstance and a Second Chance

The Low Down on the Down Low

Negotiating a Fair Price for the Norvir Tablet

» More

Most Talked About

(Un)deniable Evidence: A college professor takes on AIDS naysayers in his latest book (36)

Mom Imprisoned for Posting HIV Patient’s Medical Info Online (29)

New California Budget Slashes $55.5 Million From AIDS Funds (24)

CVS Criticized for Condom Lockup in Communities of Color (21)

Negotiating a Fair Price for the Norvir Tablet (13)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

May 20, 2008

New HIV Drug Discovery

In their discovery of a new way to inhibit formation of HIV’s protease enzyme, scientists may have identified a new drug target, according to new data published in the August 2008 issue of Biopolymers and reported today by ScienceDaily.

Protease is a doughnut-shaped enzyme involved in processing viral proteins and assembling them into new infectious viruses. It is currently the target of a handful of drugs called protease inhibitors, all of which bind to and block the hole in the doughnut shape.

Heather Carlson, PhD, a professor of chemistry at the University of Michigan, and her colleagues used computer models of the protease enzyme to discover a new part of the enzyme’s structure that would be vulnerable to chemical inhibition. They found that before the protease assumes its doughnut shape, two ends have to bind together to close the circle. Where these two flaps join is the site that Carlson’s team chose to focus on.

Using their computer models, they developed a chemical inhibitor that was successful at stopping the two ends from joining and the enzyme from maturing into its final shape. The chemical inhibitor they developed is too weak to work as a drug in the human body, but Carlson’s discovery does offer a potential new target for drug development.

Search: Heather Carlson, University of Michigan, Biopolymers, protease


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 3 (of 3 total)    

Sean Cruz, , 2009-04-07 00:42:52
The above statement is seen to be contradictory. The situation is very critical and need an experience complainer to resolve it. Sean Cruz

pablo, Newport Beach, CA, 2008-06-16 09:46:23
A CURE... A medium to STOP the virus. A Key to disrupting and ultimatelly destroying the virus and render it useless. THAT is what we mostly need. We crave the news of such discovery to be done ASAP. Yes Current drugs are life savers and all but we know little about the long term side effects of such chemicals. Even today, under the "best" prescription of drug treatments. We don't know the long time effects of these. A CURE is desperatelly needed. not another drug...

Nate HJohnson, Cincinnati, 2008-05-21 11:37:37
As a consumer of protease inhibitors since 2 days after their widespread release I have great interest in this new development. I am a member of the AIDS Clinical Trials national consumer board the NCAB and have a keen interest in development of new and less toxic drugs to fight, or erradicate HIV. This is exciting news!

comments 1 - 3 (of 3 total)    


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Watch Videos
Read the Blogs
Visit the Forums
Women's Hub
African American Hub
Latino Hub
Community Hub
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    lslade82
    Philadelphia
    Pennsylvania


    PolynesianPoz
    Honolulu
    Hawaii


    ChicoDelBronx
    Bronx
    New York


    clintonjrsyr
    syracuse
    New York
Click here to join POZ Personals!
Talk to Us
Poll
Question: Do you believe that treatment as prevention places too much responsibility for the general public's health on people living with HIV?
Yes
No

Survey
How is your overall health?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy